This article concerns the synthesis and biological activities of some N-(1-(3,4-dimethoxyphenyl)propan-2-yl) amides as isoquinoline precursors and compounds with smooth muscle (SM) relaxant activity. Aim: find the biological activity of N-(1-(3,4-dimethoxyphenyl)propan-2-yl) amides and compare it with papaverine, an isoquinoline alkaloid that has been known as a brain and coronary vasodilator and SM relaxant. Materials and methods: In silico simulation with the PASS online program predicts SM relaxant activity for the compounds. The amides were tested on the isolated gastric SM preparations (SMPs) from rats to determine their effects on spontaneous contractile activity (CA) compared with papaverine. The in vivo effect on the learning and memory processes of rats was also assessed. Results: the data from the isometric measurements showed that one of the compounds caused ex vivo relaxation in circular SM tissues isolated from the stomach (corpus) of male Wistar rats. Conclusion: We found that the compound’s SM relaxation uses the papaverine pathway. It also has an improving effect on the cognitive functions of learning and memory processes in rats.
The effects of 3 R ,16 S -2-hydroxyethyl apovincaminate (HEAPO, RGH-10885) compared with those of two cholinesterase inhibitors, donepezil and galantamine, were examined in naïve Wistar rats using standard active and passive avoidance tests. The active avoidance test (shuttle box) and two passive avoidance tests (step-through and step-down) were performed according to the experimental design. There were 10 groups of rats ( n = 8) and the substances studied were applied orally before each testing session. In the active avoidance test, the number of conditioned stimuli (avoidances), unconditioned stimuli (escapes) and intertrial crossings were observed. In step-down and step-through passive avoidance tests, the latencies of reactions were observed. All the studied compounds showed positive effects in the learning and memory tests, compared to the controls. It was concluded that HEAPO, donepezil and galantamine had a memory-enhancing effect in active and passive avoidance tests.
Background: Anthranilamides have attracted increasing attention due to their antispasmodic and anti-inflammatory effects. The present study aimed to comparatively evaluate the effects of three previously synthesized anthranilamides, namely 2-chloro-N-(2-(phenethylcarbamoyl)phenyl)benzamide (1), 2-amino-N-(3-chlorophenethyl)benzamide (2), and 2-(2-chloro-2-phenylacetamido)-N-(3,4-dimethoxyphenethyl)benzamide (3), on cognitive functions in rats and to find if those molecules could act as potential active substances for the treatment of diseases of cognitive dysfunctions. Preclinical evidence and in silico calculations suggest that these compounds may affect the acetylcholinesterase activity, which could indirectly enhance cognitive performance. Methods: Two-way active avoidance test, activity cage test, and two passive avoidance tests—step-through and step-down test—were performed. Naïve male Wistar rats were divided into 4 groups (8 rats in each group): the control group treated with DMSO and the experimental groups with the tested compounds, orally at a dose of 5 mg/kg. Results: The synthesized compounds did not impair the locomotor activity of the tested rats, with no apparent signs of motor suppression during the activity cage test. In the active avoidance test, compound (3) impaired both learning and the long-term memory test, compound (2) increased the number of conditioned stimuli responses on the 12th day as a sign of improved long-term memory, while compound (1) did not affect performance in this test. In the step-down test for passive avoidance learning it was established that compound (2) has a positive impact on the process of learning, whereas compound (1) improves learning, short-term memory, and long-term memory. Conclusions: Our results demonstrate that anthranilamide derivatives do not produce a pronounced depressant or stimulant effect on the central nervous system. Compounds (1) and (2) showed cognitive-enhancing properties, with effects varying depending on the behavioral paradigm applied. These findings highlight the potential of specific anthranilamide derivatives as modulators of learning and memory processes.
30 December 2021 in European Neuropsychopharmacology